| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 AMENDED |
BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | — | |
| 2026 AMENDED |
BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | — | |
| 2026 2nd Quarter - Report |
BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | — |